Cargando…
Treatment and Prevention of Lung Cancer Using a Virus-Infected Reprogrammed Somatic Cell-Derived Tumor Cell Vaccination (VIReST) Regime
Lung cancer is one of the most commonly diagnosed cancer and despite therapeutic advances, mortality remains high. The long period of clinical latency associated with lung cancer provides an ideal window of opportunity to administer vaccines to at-risk individuals that can prevent tumor progression...
Autores principales: | Zhang, Zhe, Lu, Shuangshuang, Dunmall, Louisa S. Chard, Wang, Zhizhong, Cheng, Zhenguo, Zhang, Zhongxian, Yan, Wenli, Chu, Yongchao, Gao, Dongling, Wang, Na, Li, Yang, Wang, Jiwei, Li, Yuenan, Ji, Yupei, Shan, Danyang, Li, Keke, Wang, Panpan, Dong, Yunshu, Dong, Jianzeng, Lemoine, Nick R., Pei, Duanqing, Zhang, Lirong, Wang, Yaohe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438408/ https://www.ncbi.nlm.nih.gov/pubmed/32903551 http://dx.doi.org/10.3389/fimmu.2020.01996 |
Ejemplares similares
-
Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
por: Wang, Pengju, et al.
Publicado: (2017) -
Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
por: Wang, Pengju, et al.
Publicado: (2018) -
A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma
por: Zhang, Zifang, et al.
Publicado: (2020) -
A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery
por: Ahmed, Jahangir, et al.
Publicado: (2020) -
Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment
por: Wang, Lihong, et al.
Publicado: (2022)